Feist E, Luggen ME, Nasonov EL, Yakushin SS, et al. The impact of comorbidities on the efficacy of IL-6 inhibitor olokizumab compared to adalimumab in a randomized controlled trial. Arthritis Res Ther 2025;27:213.
PMID: 41239458